[
  {
    "date": "2023-06-30",
    "symbol": "AHI",
    "period": "FY",
    "softwareincome": 542556,
    "integrationanddevelopmentincomeindollars": 107141,
    "operatingrevenue": 649697,
    "otherrevenue": 2140740,
    "revenue": 2790437,
    "generalandadministrativeexpense": 3205408,
    "employeebenefitsexpense": 5862699,
    "salesandmarketingexpense": 910399,
    "depreciationandamortisationexpense": 312558,
    "impairmentofassets": 475785,
    "gainslossesonfinancialassetsatfairvaluethroughprofitorlossmandatorilymeasuredatfairvalue": -1807829,
    "gainslossesonexchangedifferencesontranslationnetoftax": 39672,
    "subscriptioncostsindollars": -469903,
    "insurance": -1825428,
    "cloudinfrastructurecostsindollars": -563991,
    "operatingexpense": 15394328,
    "profitlossfromoperatingactivities": -12603891,
    "financeincome": 254392,
    "financecosts": 477678,
    "financeincomecost": -223286,
    "profitlossbeforetax": -12827177,
    "profitlossattributabletoownersofparent": -12827177,
    "foreigncurrencytranslationindollars": -283273,
    "othercomprehensiveincome": -283273,
    "comprehensiveincome": -13110450,
    "basicearningslosspershare": -6.94,
    "dilutedearningslosspersharefromcontinuingoperations": -6.94,
    "cashandcashequivalents": 2104584,
    "tradeandothercurrentreceivables": 311912,
    "currentprepayments": 834281,
    "currentassets": 3250777,
    "othernoncurrentfinancialassets": 829694,
    "rightofuseassets": 360455,
    "propertyplantandequipment": 152486,
    "intangibleassetsotherthangoodwill": 4313710,
    "noncurrentassets": 5656345,
    "assets": 8907122,
    "tradeandothercurrentpayables": 3467554,
    "currentleaseliabilities": 65182,
    "currentprovisionsforemployeebenefits": 628713,
    "othercurrentliabilities": 432464,
    "othercurrentfinancialliabilities": 4593913,
    "borrowings": 1433172,
    "currentliabilities": 6027085,
    "noncurrentleaseliabilities": 305082,
    "noncurrentprovisionsforemployeebenefits": 200277,
    "othernoncurrentliabilities": 346796,
    "noncurrentliabilities": 852155,
    "liabilities": 6879240,
    "netassetsliabilities": 2027882,
    "issuedcapital": 76008621,
    "capitalreserve": 1318257,
    "retainedearnings": -75298996,
    "equity": 2027882,
    "profitloss": -12827177,
    "sharesissuedforverticaacquisitionindollars": 180000,
    "sharesissuedforwellteqacquisitionindollars": 1673631,
    "capitalraising": 1195669,
    "ordinarysharesindollars": 5000000,
    "increasedecreasethroughsharebasedpaymenttransactions": 702383,
    "paymentstoserviceprovidersindollars": 117600,
    "performancerightsissued": 105000,
    "issueofequity": 8410200,
    "increasedecreasethroughexerciseofoptions": -133753,
    "othercashreceiptsfromoperatingactivities": 817335,
    "revenuefromgovernmentgrants": 2031623,
    "interestreceivedclassifiedasoperatingactivities": 858,
    "interestpaidclassifiedasoperatingactivities": 288172,
    "paymentstoandonbehalfofemployees": 9928828,
    "cashflowsfromusedinoperatingactivities": -7367184,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 67483,
    "cashflowsusedinobtainingcontrolofsubsidiariesorotherbusinessesclassifiedasinvestingactivities": -277944,
    "cashadvancesandloansmadetootherpartiesclassifiedasinvestingactivities": 1000000,
    "loanstofromrelatedparty": 120278,
    "cashflowsfromusedininvestingactivities": -669261,
    "proceedsfromissuingshares": 5000000,
    "proceedsfromborrowingsclassifiedasfinancingactivities": 2250000,
    "repaymentsofcurrentborrowings": 2732311,
    "proceedsfromissueofordinaryshares": 1975424,
    "repaymentsofborrowingsclassifiedasfinancingactivities": 1750000,
    "paymentsforshareissuecosts": 493286,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 81089,
    "cashflowsfromusedinfinancingactivities": 4168738,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": -3867707,
    "cashandcashequivalentsatbeginningperiod": 6011368,
    "effectofexchangeratechangesoncashandcashequivalents": -39077,
    "cashandcashequivalent": 2104584,
    "sharebasedpaymentonacquisitionofwellteqindollars": -1673631,
    "sharebasedpaymentonacquisitionofverticaindollars": -180000,
    "sharebasedpaymentoncapitalraisingcostsindollars": -702383,
    "sharesissuedonexercisedofperformancerightsindollars": 8410200,
    "employeeexpensestextblock": "Note 8. Employee expenses             Consolidated             30 June 2023      30 June 2022             $      $                            Salaries and wages      5,327,193       3,429,019       Superannuation contributions      489,507       322,219       Share based payments1      105,000       7,452,583       Employment taxes and insurances2      (142,380)      435,089       Other employment expenses      83,379       123,400              5,862,699       11,762,310",
    "descriptionofaccountingpolicyforbasisofpreparationpolicytextblock": "Basis of preparation",
    "goingconcernpolicytextblock": "Going concern",
    "parententityinformationpolicytextblock": "<p style=\"font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0\">Parent entity information</p><p style=\"font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify\">In accordance with the Corporations Act 2001,these financial statements present the results of the consolidated entity only. Supplementary information about the parent entity is disclosedin Note 40.</p>",
    "incometaxpolicypolicytextblock": "Income tax",
    "currentandnoncurrentclassificationpolicytextblock": "Current and non-current classification",
    "jointventurespolicytextblock": "Joint ventures",
    "investmentsandotherfinancialassetspolicytextblock": "Investments and other financial assets",
    "rightofuseassetspolicytextblock": "Right-of-use assets",
    "goodsandservicestaxpolicytextblock": "Goods and Services Tax (‘GST’) and other similar taxes",
    "scheduleofestimatedusefullifeoftheassetstextblock": "Depreciation is calculated on a straight-linebasis to write off the net cost of each item of property, plant and equipment (excluding land) over their expected useful lives as follows:",
    "scheduleofpurchaseconsiderationcashinflowoutflowtabletextblock": "Theseamounts have been calculated using the subsidiary’s results and adjusting them for differences in the accounting policies between thegroup and the subsidiary.",
    "scheduleofsoftwareincometabletextblock": "Consolidated             30 June 2023      30 June 2022             $      $                            Software development kits - per user      35,495       13,721       Software development kits - per scan      2,353       803       Software subscriptions      504,708       -              542,556       14,524",
    "scheduleofotherrevenuetabletextblock": "Consolidated             30 June 2023      30 June 2022             $      $                            Consultancy income      -       60,390       Joint venture income      -       172,170       Grant income      2,135,598       890,113       Other income      5,142       13,409       Other revenue      2,140,740       1,136,082",
    "scheduleofgrantincometabletextblock": "Grant income has been derived over the periodas follows:",
    "scheduleofemployeeexpensestabletextblock": "Consolidated             30 June 2023      30 June 2022             $      $                            Salaries and wages      5,327,193       3,429,019       Superannuation contributions      489,507       322,219       Share based payments1      105,000       7,452,583       Employment taxes and insurances2      (142,380)      435,089       Other employment expenses      83,379       123,400              5,862,699       11,762,310",
    "scheduleofprovisionforimpairmentexpensetabletextblock": "Consolidated             30 June 2023      30 June 2022             $      $                            Jana Care Inc (Note 21)      200,729       62,129       Bearn Inc (Note 24)      3,868       803,072       Body Composition Technologies Pte Ltd (Note 21)      26,188       188,271       Physimax Technologies Limited      -       (79,809)      Wellteq intangibles acquired through business combination (Note 4, Note 20)      245,000       -              475,785       973,663",
    "scheduleofcashandcashequivalenttabletextblock": "Consolidated             30 June 2023      30 June 2022             $      $                              Cash at bank1      2,104,584       6,011,368",
    "scheduleofprepaymentstabletextblock": "Consolidated             30 June 2023      30 June 2022              $       $                               Prepaid insurance      834,281       876,847       Other prepayments      -       18,966              834,281       895,813",
    "scheduleofreconciliationsofrightofuseassetswrittendowntextblock": "Reconciliations of Right-of-useassets written down value at the beginning and end of the current financial year are set out below:",
    "scheduleofwrittendownvaluesatthebeginningandendofthecurrentfinancialyeartabletextblock": "Reconciliations of the written down values atthe beginning and end of the current financial year are set out below:",
    "scheduleofrecoverableamountofthecompanysinvestmentsisreviewedateachreportingdatetabletextblock": "Consolidated             30 June 2023      30 June 2022             $      $                            Investment in Jana Care - at costs      953,010       752,281       Less: provision for impairment      (953,010)      (752,281)      Investment in Body Composition Technologies - at cost      713,550       696,779       Less: provision for impairment      (713,550)      (696,779)             -       -",
    "scheduleoftradeandotherpayablestabletextblock": "Consolidated             30 June 2023      30 June 2022              $       $                              Trade payables      2,810,643       136,372       Accrued Expenses      405,015       216,788       Employment related payables      251,896       147,609              3,467,554       500,769",
    "scheduleofemployeebenefitstextblock": "Consolidated            30 June 2023      30 June 2022       Current       $       $                              Annual leave      628,713       383,236",
    "scheduleofloanstootherentitiestextblock": "Consolidated             30 Jun 2023      30 Jun 2022             $      $                            Investment in Bearn - at cost      806,940       803,072       Less: provision for impairment      (806,940)      (803,072)             -       -",
    "scheduleofreconciliationloanbalanceatthebeginningandendofthecurrentfinancialyeartextblock": "Reconciliation of the loan balance at the beginning and end of thecurrent financial year are set out below:",
    "scheduleofinterestbearingborrowingstextblock": "Consolidated             30 June 2023      30 June 2022             $       $                            R&D prepayment loan 1      1,000,000       700,000       Other loans2      207,712       410,171       Convertible notes payable3      225,460       -              1,433,172       1,110,171",
    "scheduleofinterestbearingborrowingsmovementtextblock": "Interest bearing borrowings movement     Opening balance at  1 July    2022      Additions      Repayment      Closing  balance at 30 June 2023       R&D prepayment loan      700,000       1,000,000       (700,000)      1,000,000       Other loans      410,171       1,195,000       (1,397,459)      207,712       Convertible notes payable      -       1,975,460       (1,750,000)      225,460              1,110,171       4,170,460       (3,847,459)      1,433,172",
    "disclosureofleaseliabilitiestextblock": "Consolidated             30 June 2023      30 June 2022             $       $                            Current liability      65,182       51,213       Non-current liability      305,082       -              370,264       51,213",
    "scheduleofothercurrentliabilitiestabletextblock": "Consolidated             30 June 2023      30 June 2022              $       $                                                     Deferred revenue      59,589       -       Deferred acquisition consideration      372,875       -              432,464       -",
    "scheduleofreconciliationofdeferredrevenuetabletextblock": "Reconciliation ofdeferred revenue",
    "scheduleofothernoncurrentliabilitiestabletextblock": "Consolidated             30 June 2023      30 June 2022              $       $                              Deferred acquisition consideration      346,796       -",
    "scheduleofthereconciliationofthepresentvalueofdeferredconsiderationatbusinesscombinationtobalancetabletextblock": "The reconciliation of the present value of deferredconsideration at business combination to balance date is shown below:",
    "scheduleofordinarysharestabletextblock": "Ordinary shares have no par value. There is nolimit to the authorised share capital of the Company. There are no externally imposed capital requirements.",
    "scheduleofmovementsinordinarysharecapitaltabletextblock": "Movements in ordinary share capital",
    "scheduleofreservestabletextblock": "Consolidated             30 June 2023      30 June 2022             $      $                            Equity Remuneration Reserve      1,601,530       9,338,100       Foreign currency reserve      (283,273)      -              1,318,257       9,338,100",
    "disclosureofequitycompensationreserveexplanatory": "The reserve is used to recognise the value ofequity benefits provided to employees and Directors as part of their remuneration, and other parties as part of their compensation forservices.",
    "disclosureofforeigncurrencyreserveexplanatory": "The reserve is used torecognise exchange differences arising from the translation of the financial statements of foreign operations to Australian dollars.",
    "scheduleofoptionswereexercisedtabletextblock": "During the year ended 30 June 2022, the followingoptions were exercised:",
    "scheduleofoptionsoverunissuedsharesoccurredtabletextblock": "During the current year the following movements in options over unissuedshares occurred for share-based payments:",
    "scheduleofblackscholesoptionvaluationmethodologytabletextblock": "The options issued during the year ended 30 June2023 were valued using the Black-Scholes option valuation methodology, as follows:",
    "scheduleofgrantsoccurredwithrespecttoperformancerightstabletextblock": "During the financial year ended 30 June 2023, the following grantsoccurred with respect to performance rights during the period:",
    "scheduleofnumberofperformancerightsoutstandingoverunissuedordinarysharestabletextblock": "The number of performance rights outstanding overunissued ordinary shares at 30 June 2023 is as follows:",
    "scheduleoftotalexpensesarisingfromsharebasedpaymenttransactionstabletextblock": "Total expenses arising from share-based paymenttransactions recognised during the period were as follows:",
    "scheduleofconsolidatedentitysinterestbearingfinancialinstrumentstabletextblock": "At the reporting date, the interest profile ofthe consolidated entity’s interest-bearing financial instruments was:",
    "scheduleofothervariablesremainconstanttabletextblock": "A change of 100 basis points in interest ratesat the reporting date would have increased / (decreased) equity and profit or loss by the amounts shown below. This analysis assumes thatall other variables remain constant.",
    "scheduleofcontractualmaturitiesoffinancialliabilitiestabletextblock": "The following are the contractual maturities offinancial liabilities, including estimated interest payments and excluding the impact of netting agreements:",
    "scheduleoffairvaluesoffinancialassetsandliabilitiestabletextblock": "The fair values of financial assets and liabilities,together with their carrying amounts in the statement of financial position, for the consolidated entity are as follows:",
    "scheduleofdirectorsofadvancedhealthintelligenceltdduringthefinancialyeartabletextblock": "The following persons were Directors of AdvancedHealth Intelligence Ltd during the financial year:",
    "scheduleofauthorityandresponsibilityforplanningdirectingandcontrollingthemajoractivitiesoftheconsolidatedentitytabletextblock": "The following person also had the authority andresponsibility for planning, directing and controlling the major activities of the consolidated entity, directly or indirectly, duringthe financial year:",
    "scheduleofsummarisedstatementoffinancialpositiontabletextblock": "Summarised financial information",
    "disclosureoflevel3triageinvestmenttabletextblock": "Movements in the level 3 Triage investment duringthe current and previous financial year are set out below:",
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": "P3Y",
    "othercurrentfinancialassets": 2776308,
    "propertyplantandequipmentrecognisedasofacquisitiondate": 67483,
    "shorttermemployeebenefitsexpense": 382893,
    "cashequivalents": 144419,
    "cashonhand": 422331,
    "cashflowsfromusedininvestingactivitiesdiscontinuedoperations": -144387,
    "cashflowsfromusedininvestingactivitiescontinuingoperations": 422331,
    "computersoftware": 35495,
    "incomefromgovernmentgrantsrelatedtoagriculturalactivity": 2135598,
    "otherincome": 5142,
    "taxeffectoftaxlosses": 2018241,
    "otheremployeeexpense": 14624,
    "boostingapprenticeshipcommencementgrantindollarspershare": -13148,
    "exportmarketdevelopmentgrant": 89585,
    "totalgrantincome": 2135598,
    "consultingadvisory": 1230098,
    "corporateexpenses": 452893,
    "telecommunicationsit": 237390,
    "administrativeexpense": 167577,
    "researchanddevelopmentexpense": 25287,
    "travelexpense": 447819,
    "legalproceedingsprovision": 364505,
    "otherexpensebynature": 64581,
    "taxbenefitarisingfrompreviouslyunrecognisedtaxlosstaxcreditortemporarydifferenceofpriorperiodusedtoreducedeferredtaxexpense": 97658,
    "expensefromsharebasedpaymenttransactionswithemployees": 117600,
    "shorttermemployeebenefitsaccruals": 3205408,
    "wagesandsalaries": 5327193,
    "otherlongtermbenefits": 489507,
    "adjustmentsforsharebasedpayments": 105000,
    "employmenttaxesandinsurances": -142380,
    "otherexpensebyfunction": 83379,
    "totalemployeeexpenses": 5862699,
    "janacareincnote21": 200729,
    "bearnincnote24": 3868,
    "bodycompositiontechnologiespteltdnote21": 26188,
    "wellteqintangiblesacquiredthroughbusinesscombinationnote4note20": 245000,
    "totalprovisionforimpairmentexpense": 475785,
    "currenttaxexpenseincome": -2867508,
    "adjustmentsforcurrenttaxofpriorperiod": 2867508,
    "deferredtaxexpenseincomerelatingtooriginationandreversaloftemporarydifferences": 503587,
    "deferredtaxexpenseincome": -503587,
    "lossfromcontinuingoperationsbeforeincometaxexpense": -12827177,
    "taxeffectofforeigntaxrates": -3830489,
    "capitalraisingcostsclaimed": -1006095,
    "taxeffectfromchangeintaxrate": 102842,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 4377190,
    "revenuelossesavailabletooffsetagainstfuturetaxableincome": 6836877,
    "accruedexpensesandleaveprovisions": 257778,
    "deductibleequityraisingcosts": 689315,
    "netdeferredtaxliabilities": 61291,
    "intangibleassetsunderdevelopment": 307298,
    "copyrightspatentsandotherindustrialpropertyrightsserviceandoperatingrights": 273005,
    "investmentproperty": 1547215,
    "foreignexchangegain": 66130,
    "netdeferredtaxassets": 9906649,
    "taxrateeffectofforeigntaxrates": 0.25,
    "weightedaverageshares": 184836915,
    "adjustedweightedaverageshares": 184836915,
    "dilutedearningslosspershare": -6.94,
    "cashatbank": 2104584,
    "adjustmentsfordepreciationandamortisationexpense": 371273,
    "impairmentlossrecognisedinprofitorlosstradereceivables": 2283614,
    "gainslossesonexchangedifferencesontranslationrecognisedinprofitorloss": -304954,
    "accruedinterests": 230785,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": -234955,
    "decreaseinprepayments": 61532,
    "increasedecreaseindeferredincome": 59589,
    "adjustmentsforincreasedecreaseintradeandotherpayables": 2966786,
    "currenttradereceivables": 401358,
    "allowanceaccountforcreditlossesoffinancialassets": 235357,
    "grosstradereceivables": 166001,
    "gstreceivable": 145911,
    "insuranceprepaid": 834281,
    "prepayments": 834281,
    "balancesontermdepositsfromcustomers": 65485,
    "investmentintriageatfairvaluethroughprofitandloss": 764209,
    "otherfinancialassets": 829694,
    "adjustmentsfordepreciationexpense": 39685,
    "additionstorightofuseassets": 364941,
    "depreciationrightofuseassets": 39685,
    "costofsales": 55735,
    "accumulateddepreciation": -55735,
    "otherpropertyplantandequipment": 152486,
    "acquisitionsthroughbusinesscombinationspropertyplantandequipment": 104074,
    "depreciationexpense": 102794,
    "goodwill": 3210161,
    "customerrelationship": 158000,
    "adjustmentsforprovisions": -158000,
    "inprocessrdsoftwares": 374000,
    "brandnames": 87000,
    "lessprovisionforimpairment": -87000,
    "applicationdevelopment": 1972994,
    "amortisationintangibleassetsotherthangoodwill": 1243445,
    "otherintangibleassets": 729549,
    "intangibleassetsandgoodwill": 4313710,
    "additionsotherthanthroughbusinesscombinationsintangibleassetsotherthangoodwill": 607176,
    "impairmentlossrecognisedinprofitorlossintangibleassetsandgoodwill": 158000,
    "amortisationexpense": 257435,
    "investmentpropertyfairvalueusedasdeemedcost": 953010,
    "additionsotherthanthroughbusinesscombinationsinvestmentproperty": 200729,
    "impairmentlossrecognisedinprofitorlossinvestmentproperty": 200729,
    "tradepayablesandotherpayables": 2810643,
    "currentaccruedexpensesandothercurrentliabilities": 405015,
    "employmentrelatedpayables": 251896,
    "tradeandotherpayables": 3467554,
    "annualleaveliability": 628713,
    "longserviceleaveliability": 200277,
    "consumerloans": 806940,
    "lessprovisionforimpairments": -806940,
    "interestincomeonimpairedfinancialassetsaccrued": 121131,
    "repaymentsofborrowings": -150700,
    "impairmentlossrecognisedinprofitorlossintangibleassetsotherthangoodwill": -3868,
    "impactonforeignexchangerates": 33437,
    "interestbearingborrowingsmovementadditions": 1000000,
    "interestbearingborrowingsmovementrepayment": -700000,
    "othernoncurrentfinancialliabilities": 305082,
    "otherliabilities": 370264,
    "balancesonotherdepositsfromcustomers": 370264,
    "operatingleaseincome": 400140,
    "repaymentofleaseliability": 81089,
    "deferredrevenueforothercurrentliabilities": 59589,
    "deferredacquisitionconsideration": 372875,
    "regulatorydeferralaccountdebitbalances": 59589,
    "advancesreceivedduringtheyearnetofrevenuerecognised": 59589,
    "deferredrevenueacquiredthroughbusinesscombination": 150016,
    "revenuethatwasincludedincontractliabilitybalanceatbeginningofperiod": 150016,
    "deferredconsiderationcurrentportions": -372875,
    "deferredconsiderationnoncurrentportion": -346796,
    "totaldeferredconsideration": 719671,
    "issuedcapitalordinaryshare": 217703969,
    "issuedcapitalordinaryshares1": 76008621,
    "issuedsharecapital": 217703969,
    "sharemovementsduringtheperiodordinaryshares": 217703969,
    "sharemovementduringtheperiodordinaryshares": 76008621,
    "shareplacement": 20000000,
    "sharesplacement": 5000000,
    "sharesissuedonexerciseofperformancerights": 10500000,
    "sharesissuedonexerciseofperformanceright": 8410200,
    "shareissueverticaacquisition": 1500000,
    "sharesissueverticaacquisitionnote4": 180000,
    "shareissuewellteqacquisition": 17804587,
    "sharesissuewellteqacquisition": 1673631,
    "sharesissuedtoserviceproviders": 1150000,
    "sharesissuedtoserviceprovider": 117600,
    "lessshareissuecost": -1195669,
    "ordinarysharesdate": "1 July 2022",
    "numberofsharesissuedandfullypaid": 166749382,
    "issueprice": 61822859,
    "shareissuerelatedcost": 76008621,
    "reserveofequitycomponentofconvertibleinstruments": 1601530,
    "foreigncurrencyreserves": 283273,
    "equitycompensationreserve": 1601530,
    "fairvaluevestingexpenseofoptionsandperformancerights": 807383,
    "proceedsfromexerciseofoption": -8410200,
    "lapseofperformancerightsandoptions": -133753,
    "reserveofchangeinvalueofforeigncurrencybasisspreads": 283273,
    "deferredtaxexpenseincomerecognisedinprofitorloss": 283273,
    "dateofgrantofsharebasedpaymentarrangement": "01/02/2019",
    "exercisepriceshareoptionsgranted2019": 0.65,
    "descriptionofvestingrequirementsforsharebasedpaymentarrangement": "31/12/2020",
    "expirydate": "2023-12-31",
    "numberofoptionsgranted": 200000,
    "numberofoutstandingshareoption": 7786958,
    "weightedaverageexercisepriceofshareoptiongrantedinsharebasedpaymentarrangement2019": 0.839,
    "grantedduringstheyear": 2500000,
    "grantedduringtheyear": 0.35,
    "forfeitedcancelledduringtheyears": -1200000,
    "forfeitedcancelledduringtheyearindollars": 0.608,
    "exercisables": 7786958,
    "exercisable": 0.839,
    "dategranted": "2023-06-13",
    "exerciseprice": 0.35,
    "riskfreeinterestrateused": 0.041,
    "volatilityapplied": 1.37,
    "valueperoption": 0.281,
    "rightsgranted": 500000,
    "fairvalueperrightatgrantdate": 0.21,
    "sharesissuedtoadvisersasremuneration": 117600,
    "employeesremuneration": 105000,
    "optionsissuedtoadvisersasremuneration1": 702383,
    "expensesarisingfromreinsuranceheld": 924983,
    "financialassets": 806940,
    "financialliabilities": 1803436,
    "assetslesscurrentliabilities": -996496,
    "profitorlossincrease": 21046,
    "profitorlossdecrease": -21046,
    "equityincrease": 21046,
    "equity1decrease": -21046,
    "weightedaverageinterestrate": 0.1125,
    "carryingamount": 3467554,
    "contractualcashflows": 3467554,
    "notlaterthansixmonths": 3467554,
    "laterthansixmonthsandnotlaterthantwelvemonths": 46800,
    "laterthanoneyearandnotlaterthantwoyears": 95472,
    "laterthantwoyearsandnotlaterthanfiveyears": 255197,
    "othercashandcashequivalents": 2104584,
    "tradeandotherreceivables": 311912,
    "tradeandotherpayablesrecognisedasofacquisitiondate": 3467554,
    "interestexpenseonborrowings": 1433172,
    "otherpayables": 346796,
    "descriptionofnatureofrelatedpartyrelationship": "Interim Non-Executive Chairman",
    "descriptionofnatureofentitysoperationsandprincipalactivities": "Company Secretary and Chief Financial Officer",
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 928274,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 30934,
    "keymanagementpersonnelcompensation": 959208,
    "descriptionofaggregatelicensefeeinvestment": "US$2m",
    "numberofsharesissued": 250000,
    "auditorsremunerationforpkfbrisbaneauditservices": 197000,
    "auditorsremunerationfortaxservices": 15730,
    "auditorsremunerationforotherservices": 1200,
    "auditorsremuneration": 213930,
    "othercomprehensiveincomenetoftaxgainslossesonremeasurementsofdefinedbenefitplans": -10541904,
    "netassets": 4943354,
    "foreigncurrencytranslationreserve": 232801,
    "triageinvestment": 764209,
    "adjustmentsforfairvaluegainslosses": -1807829,
    "netforeignexchangeloss": 6956,
    "requiresagreementamount": 10000000,
    "convertibleloanfacility": 1500000,
    "amortisationmethodintangibleassetsotherthangoodwill": "5 years",
    "insurancerevenuecontractualservicemarginrecognisedinprofitorlossbecauseoftransferofservices": 1096358,
    "cashandnoncashconsiderationdescription": "●1,500,000 AHI fully paid ordinary shares issued on closing,escrowed for 24 months from issue;●US$100,000 cash payable on transaction close;●US$250,000 payable 1 year from closing; and●US$250,000 payable 2 years from closing.",
    "marketprice": 0.12,
    "additionalleasetermrightofuseassets": "P3Y",
    "cashoutflowforleases": 487469,
    "incrementalborrowingrate": 0.078,
    "leaseliabilities": 400140,
    "usefullifemeasuredasperiodoftimeintangibleassetsotherthangoodwill": "P3Y",
    "steadyrateperiod": "P2Y",
    "descriptionofdiscountratesappliedtocashflowprojections": 0.58,
    "projectedrevenuegrowthrate": 0.02,
    "descriptionofgrowthrateusedtoextrapolatecashflowprojections": 1.1,
    "operatingcostspercentage": 0.1,
    "taxrateeffectoftaxlosses": 0.58,
    "taxrateeffectofrevenuesexemptfromtaxation": 0.02,
    "increaseinoperatingcostsrate": 0.1,
    "taxrateeffectofimpairmentofgoodwill": 0.675,
    "amortisationrateintangibleassetsotherthangoodwill": 0.982,
    "proportionofownershipinterestsheldbynoncontrollinginterests": 0.5,
    "numberofparties": 2,
    "agreementamount": 500000,
    "advanceamount": 1000000,
    "percentageofloaninterest": 0.08,
    "scaleofinterest": 0.15,
    "loanusers": 2000000,
    "amountofmaturitydate": 1000000,
    "accruedincomeincludingcontractassets": 121131,
    "loanspayableinbreachwhichpermittedlendertodemandacceleratedrepayment": 100973,
    "taxprepaymentloanreceived": 1000000,
    "borrowingsinterestrate": 0.15,
    "interestbearingliabilitiesaverageratepaid": 0.075,
    "convertiblenotefacevalue": 1,
    "sharefloorprice": 0.5,
    "undiscountedfinanceleasepaymentstobereceived": 299129,
    "incrementalborrowingpercentage": 0.1,
    "interestexpenseonleaseliabilities": 211191,
    "leaseoverthepremisesforanadditionalperiod": "P3Y",
    "interestpaidclassifiedasfinancingactivities": 20245,
    "tradeandotherpayablestorelatedparties": 250000,
    "marketvaluepricepershare": 0.12,
    "vestedshares": 500000,
    "sharesreservedforissueunderoptionsandcontractsforsaleofshares": 400000,
    "otherfeeandcommissionincome": 315000,
    "legalfee": 135562,
    "unlistedoptionsissued": 2500000,
    "weightedaverageexercisepriceofshareoptionsoutstandinginsharebasedpaymentarrangement2019": 0.28,
    "optionsexpire": "2025-06-13",
    "weightedaverageexercisepriceofshareoptionsinsharebasedpaymentarrangementexercisedduringperiodatdateofexercise2019": 0.35,
    "weightedaveragecontractuallife": "P11M6D",
    "optionsissued": 2500000,
    "numberofshareoptionexercisedinsharebasedpaymentarrangement": 500000,
    "weightedaverageshareprice2019": 0.21,
    "righttoacquirebusiness": 0.4,
    "considerationpaidreceived": 2000000,
    "noofcustomers": 5000000,
    "investmentfundspercentagecontributedtofairvalueofplanassets": 0.2,
    "investmentincome": 2000000,
    "numberofusers": 10000000,
    "proceedsfromexerciseofoptions": 200000,
    "benefitspaidorpayable": 50000,
    "commitedremainingbalance": 50000,
    "proportionofownershipinterestinjointventure": 0.5,
    "otherfeeandcommissionexpense": 5000000,
    "percentageofentitysrevenue": 0.25,
    "percentageofvotingequityinterestsacquired": 0.25,
    "percentageofclaimcost": 0.435,
    "issueofconvertibleinstruments": 1500000,
    "borrowingsinterestratebasis": "10%",
    "conversionpricepershare": 0.3,
    "conversionoffloorprice": 0.35,
    "borrowingsadjustmenttointerestratebasis": 0.1,
    "entityregistrantname": "ADVANCED HEALTH INTELLIGENCE LTD",
    "tradingsymbol": "AHI",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "--06-30",
    "entitycommonstocksharesoutstanding": 217703969,
    "amendmentflag": "false",
    "entitycentralindexkey": 1815436,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "2023-06-30",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "false",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "000-49843",
    "entityincorporationstatecountrycode": "C3",
    "entityaddressaddressline1": "71-73 South Perth Esplanade",
    "entityaddressaddressline2": "Unit 5",
    "entityaddresscityortown": "South Perth",
    "entityaddresspostalzipcode": "WA 6151",
    "entityaddresscountry": "AU",
    "contactpersonnelname": "Mr Scott Montgomery",
    "cityareacode": 61,
    "localphonenumber": "8 9316 9100",
    "security12btitle": "American Depositary Shares, each representing twenty eight Ordinary Shares",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "documentfinstmterrorcorrectionflag": "false",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "auditorname": "PKF BRISBANE AUDIT",
    "auditorlocation": "Brisbane",
    "auditorfirmid": 6622
  },
  {
    "date": "2022-06-30",
    "symbol": "AHI",
    "period": "FY",
    "primaryrevenuesoftwaredevelopmentkitsperuser": 13721,
    "primaryrevenuesoftwaredevelopmentkitsperscan": 803,
    "secondaryrevenueintegrationanddevelopmentincome": 182685,
    "otherrevenue": 245969,
    "revenue": 269203,
    "employeebenefitsexpense": 11762310,
    "salesandmarketingexpense": 2106498,
    "generalandadministrativeexpense": 6008007,
    "impairmentofassets": 1524752,
    "profitlossfromoperatingactivities": -21401567,
    "financeincome": 155255,
    "financecosts": 163822,
    "financeincomecost": -8567,
    "profitlossbeforetax": -20966956,
    "incometaxexpensecontinuingoperations": -890113,
    "profitlossattributabletoownersofparent": -19962718,
    "comprehensiveincome": -20076843,
    "basicearningslosspershare": -13.08,
    "dilutedearningslosspershare": -13.08,
    "cashandcashequivalents": 6011368,
    "tradeandothercurrentreceivables": 51176,
    "currentprepayments": 895813,
    "currentassets": 6925107,
    "othernoncurrentfinancialassets": 37500,
    "rightofuseasset": 35199,
    "propertyplantandequipment": 94767,
    "noncurrentheldtomaturityinvestments": 2565082,
    "intangibleassetsotherthangoodwill": 972732,
    "noncurrentassets": 3852108,
    "assets": 10777215,
    "tradeandothercurrentpayables": 500769,
    "currentprovisionsforemployeebenefits": 383236,
    "borrowings": 1110171,
    "currentleaseliabilities": 51213,
    "currentliabilities": 2044842,
    "noncurrentprovisionsforemployeebenefits": 62861,
    "noncurrentliabilities": 62861,
    "liabilities": 2107703,
    "assetsnet": 8669512,
    "issuedcapital": 61822859,
    "capitalreserve": 9338100,
    "retainedearnings": -62491447,
    "equity": -2499012,
    "profitloss": -267806,
    "issueofequity": -1996500,
    "optionsexercised": 1174905,
    "ordinarysharesnasdaq": 16706783,
    "costsofcapitalraisingnasdaq": -2856327,
    "repaymentofnotes": 3125964,
    "increasedecreasethroughsharebasedpaymenttransactions": 1050238,
    "dividendspaid": 7452583,
    "othercashreceiptsfromoperatingactivities": 266212,
    "revenuefromgovernmentgrants": 890113,
    "interestreceivedclassifiedasoperatingactivities": 98,
    "interestpaidclassifiedasoperatingactivities": 163822,
    "paymentstoandonbehalfofemployees": 10851400,
    "cashflowsfromusedinoperatingactivities": -9858799,
    "purchaseofpropertyplantandequipmentclassifiedasinvestingactivities": 86269,
    "loanstofromrelatedparty": -171500,
    "paymentsforproceedsfrominvestments": 3126950,
    "cashflowsfromusedininvestingactivities": -3384719,
    "proceedsfromborrowingsclassifiedasfinancingactivities": 1077069,
    "paymentsofleaseliabilitiesclassifiedasfinancingactivities": 86912,
    "proceedsfromissuingshares": 18233320,
    "paymentsforshareissuecosts": 2141090,
    "cashflowsfromusedinfinancingactivities": 17082387,
    "increasedecreaseincashandcashequivalentsbeforeeffectofexchangeratechanges": 3838869,
    "cashandcashequivalentsatbeginningperiod": 2172499,
    "cashandcashequivalent": 6011368,
    "cashatbank": 6011368,
    "employeeleaveliabilitiestextblock": "Note 15Employee leave liabilities ",
    "interestbearingborrowingstextblock": "Note 16Interest bearing borrowings ",
    "loanstootherentitiestextblock": "Note 27Loans to other entities ",
    "disclosureofparententityinformationtextblock": "Note 30Parent entity information ",
    "incometaxpolicypolicytextblock": "(b)Incometax ",
    "goodsandservicestaxpolicytextblock": "(c)Goodsand services tax ",
    "revenueandotherincomepolicytextblock": "(g)Revenueand other income ",
    "rightofuseassetspolicytextblock": "(l)Right-of-useAssets ",
    "investmentsinequityaccountedinvesteespolicytextblock": "(m)Investmentsin equity-accounted investees ",
    "investmentsandotherfinancialassetspolicytextblock": "(n)Investments and Other Financial Assets ",
    "issuedcapitalpolicytextblock": "(q)Issued capital ",
    "criticalaccountingestimatesandjudgementsploicytextblock": "(s)Critical accounting estimates and judgements ",
    "currentandnoncurrentclassificationpolicytextblock": "(t)Current and non-current classification ",
    "scheduleofprepaymentstabletextblock": "                2022              2021                     A$              A$           Current assets                                    Prepaid NASDAQ IPO costs              -                   863,856           Prepaid insurance              876,847                   22,525           Other prepayments              18,966                   18,974                          895,813                   905,355       ",
    "rightofuseassetstabletextblock": "                2022              2021                     A$              A$           Non-current assets                                    Balance at the start of the financial year              105,594                   175,992           Amortisation expense              (70,395    )              (70,398    )      Balance at the end of the financial year              35,199                   105,594        ",
    "intangibleassetstabletextblock": "                2022              2021                     A$              A$           Balance at the start of the financial year              1,215,915                   1,373,492           Application development costs incurred during the year              -                   78,279           Amortisation              (243,183    )              (235,856    )      Balance at the end of the financial year              972,732                   1,215,915        ",
    "scheduleoftradeandotherpayablestabletextblock": "            2022      2021             A$      A$       Current liabilities                    Trade payables and other payables      136,372       339,345       Accrued expenses      216.788       68,000       Employment related payables      147,609       147,712              500,769       555,057    ",
    "scheduleofemployeeleaveliabilitiestabletextblock": "                2022              2021                     A$              A$           Current                                    Annual leave liability              383,236                   438,991        ",
    "scheduleofinterestbearingborrowingstextblock": "            2022      2021             A$      A$       Current                    Convertible notes-ACAM1         -       1,644,081       Convertible notes-iGGF1      -       534,061       Total convertible notes      -       2,178,142       R&D tax prepayment loan2      700,000       -       Other loans3      410,171       -              1,110,171       2,178,142    ",
    "disclosureofleaseliabilitiestextblock": "            2022      2021             A$      A$       Current liability      51,213       86,912       Non-current liability      -       51,213       Balance at the end of the financial year      51,213       138,125    ",
    "scheduleofreportingperiodthefollowingperformancerightsweregrantedtabletextblock": "      Grant Date     No of Rights      Expiry Date     Fair Value per Right at Grant Date      Vesting      6 Nov 2020      50,000      6 Nov 2026     A$    0.85      6 Nov 2021      11 Dec 2020      10,000,000      16 Dec 2025     A$0.68-$0.93      Performance based with 5 milestones      Total      10,050,000                        ",
    "scheduleofnumberofperformancerightsoutstandingoverunissuedordinarysharestabletextblock": "      Grant Date     No of Rights      Expiry Date     Fair Value per Right at Grant Date      Vesting      3 Mar 2017      2,000,000      3 Mar 2022     A$0.72      Vested and exercised      3 Sep 2018      3,000,000      3 Sep 2021     A$0.185      Vested and exercised   ",
    "scheduleofperformancerightswithvestingcriteriabasedonlengthofservicewerevaluedusingthecompanystabletextblock": "      Milestone     Number of rights granted      Share price target      Risk free interest rate used      Volatility applied      Value per Right (cents)       1      2,000,000      A$   1.20       0.04%      125%      67.8       2      2,000,000      A$1.30       0.09%      125%      78.7       3      2,000,000      A$1.40       0.10%      125%      85.1       4      2,000,000      A$1.50       0.22%      125%      90.5       5      2,000,000      A$1.70       0.35%      125%      93.1    ",
    "scheduleofothervariablesremainconstanttabletextblock": "            Profit or Loss      Equity              1%       1%      1%       1%              increase       decrease       Increase       Decrease       2022                                      Variable rate instruments     A$60,114      A$(60,114)     A$60,114      A$(60,114)   ",
    "scheduleofrecoverableamountofthecompanysinvestmentsisreviewedateachreportingdatetabletextblock": "            Restated Triage      Jana Care      BCT             A$      A$      A$       Balance at 1 July 2021      1,362,717       690,153       680,008       Additional investment      3,126,950       -       -       Interest and other costs      -       83,031       16,771       Foreign exchange movement      (10,779)      (20,903)      -       Provision for impairment      (1,913,806)      (752,281)      (696,779)      Balance at 30 June 2022      2,565,082       -       -   ",
    "disclosureoffinancialassetsorliabilitytabletextblock": "            Leve    l      Level    2      Level    3             A$      A$      A$       Consolidated – 2022                           Unlisted shares 1      -       -       2,565,082       Total      -       -       2,565,082                                      Consolidated – 2021                              Unlisted shares 1      -       -       -       Total      -       -       -    ",
    "disclosureoflevel3triageinvestmenttabletextblock": "      Consolidated         Triage Investment                      A$           Balance at 1 July 2020         -           Additions              1,362,717           Impairment recognised in profit or loss              (1,362,717    )      Balance at 30 June 2021              -           Additions              3,116,171           Impairment recognised in profit or loss              (551,089    )      Restated Balance at 30 June 2022              2,565,082       ",
    "performanceobligation": "As defined in the contract either at the start of the service, or as requested by the customer over the life of the contract.",
    "timingofrecognition": "Recognised at the point in time, a service is delivered to the customer under the terms of the contract.",
    "usefullifemeasuredasperiodoftimepropertyplantandequipment": 7,
    "consultancyincome": 60390,
    "jointventureincome": 172170,
    "otherincomes": 13409,
    "revenueandoperatingincome": 245969,
    "amortisationdepreciationexpense": 363695,
    "deferredtaxexpenseincomerecognisedinprofitorloss": -137374,
    "consultingadvisory": 553087,
    "otheremployeeexpense": 745452,
    "telecommunicationsit": 202560,
    "sellinggeneralandadministrativeexpense": 431927,
    "outsourceddevelopmentcosts": 164050,
    "subscriptioncosts": 266844,
    "doubtfuldebtsexpense": 235357,
    "insuranceexpense": 1343312,
    "otherexpensebyfunction": 1839097,
    "totalgeneraladministration": 6008007,
    "provisionforimpairmentexpense": 1524752,
    "wagesandsalaries": 3429019,
    "otherlongtermbenefits": 322219,
    "expensefromsharebasedpaymenttransactionsinwhichgoodsorservicesreceiveddidnotqualifyforrecognitionasassets": 7452583,
    "employmenttaxesandinsurances": 435089,
    "otheremploymentexpenses": 123400,
    "currenttaxexpenseincome": -2651576,
    "adjustmentsforcurrenttaxofpriorperiod": 2651576,
    "researchanddevelopmentexpense": 890113,
    "deferredtaxexpenseincomerelatingtooriginationandreversaloftemporarydifferences": 7168453,
    "deferredtaxexpenseincome": -7168453,
    "othercomprehensiveincomebeforetaxgainslossesonremeasurementsofdefinedbenefitplans": -19962718,
    "lossfromcontinuingoperationsbeforeincometaxexpense": -20852831,
    "taxeffectofforeigntaxrates": -5213208,
    "capitalraisingcostsclaimed": -301743,
    "otherexpensebynature": 537009,
    "unusedtaxlossesforwhichnodeferredtaxassetrecognised": 4138764,
    "taxbenefit": -248842,
    "foreignexchangegain": 34344,
    "currentprepaidexpenses": 223953,
    "deferredtaxliabilities": 258297,
    "revenuelossesavailabletooffsetagainstfuturetaxableincome": 5428055,
    "accruedexpensesandleaveprovisions": 199877,
    "deductibleequityraisingcosts": 1139489,
    "leaseliabilities": 4004,
    "intangibleassetsunderdevelopment": 246503,
    "copyrightspatentsandotherindustrialpropertyrightsserviceandoperatingrights": 243403,
    "investmentproperty": 2565082,
    "deferredtaxassets": 7426751,
    "netdeferredtaxassets": 7168453,
    "taxrateeffectofforeigntaxrates": 0.25,
    "basicearningslossperinstrumentfromcontinuingoperationsparticipatingequityinstrumentsotherthanordinaryshares": -13.08,
    "dilutedearningslossperinstrumentfromcontinuingoperationsparticipatingequityinstrumentsotherthanordinaryshares": -13.08,
    "lossaftertaxfromcontinuingoperations": -20076843,
    "weightedaverageshares": 153488834,
    "cashandcashequivalents1": 6011368,
    "lossfromordinaryactivitiesafterincometax": -20076843,
    "depreciationandamortisationexpense": 363695,
    "depreciationamortisationandimpairmentlossreversalofimpairmentlossrecognisedinprofitorloss": 4175993,
    "sharebasedpaymentsexpense": 7452583,
    "fairvaluelossonconvertiblenotes": 781492,
    "unrealisedforeigncurrencylosses": 142836,
    "accruedinterest": -155157,
    "adjustmentsfordecreaseincreaseinprepaidexpenses": 9542,
    "adjustmentsfordecreaseincreaseintradeandotherreceivables": 192124,
    "increaseininvestments": -2565082,
    "decreaseincreaseinemployeeliabilitiesprovisions": 7106,
    "decreaseincreaseindeferredincome": -132800,
    "adjustmentsforincreasedecreaseintradeandotherpayables": -54288,
    "currenttradereceivables": 15887,
    "gstreceivable": 35289,
    "tradeandothercurrentreceivable": 51176,
    "insuranceprepaid": 876847,
    "noncurrentprepayments": 18966,
    "prepayments": 895813,
    "cashequivalents": 37500,
    "rightofuseassets": 35199,
    "adjustmentsforamortisationexpense": 70395,
    "costofsales": 55735,
    "depreciationspropertyplantandequipment": -19164,
    "closingnetbookvalue": 11044,
    "otherpropertyplantandequipment": 11044,
    "openingnetbookvalue": 25528,
    "additionsotherthanthroughbusinesscombinationsinvestmentproperty": 3126950,
    "amortisationexpense": 243183,
    "tradepayablesandotherpayables": 136372,
    "currentaccruedexpensesandothercurrentliabilities": 216.788,
    "employmentrelatedpayables": 147609,
    "othercurrentliabilities": 500815,
    "annualleaveliability": 383236,
    "longserviceleaveliability": 62861,
    "rdtaxprepaymentloan3": 700000,
    "otherloans": 410171,
    "othercurrentassets": 1110171,
    "liabilitiescurrent": 51213,
    "balancesonotherdepositsfromcustomers": 51213,
    "repaymentsofborrowingsclassifiedasfinancingactivities": 86912,
    "issuedcapitalperformanceshare": 166749382,
    "issuedcapitalperformanceshares": 61822859,
    "issuedsharecapital": 166749382,
    "issuedcapitalordinaryshares": 61822859,
    "atthestartofthefinancialyears": 136362538,
    "atthestartofthefinancialyear": 39213794,
    "sharesissuedonexerciseofperformanceright": 5000000,
    "sharesissuedonexerciseofperformancerights": 1996500,
    "sharesissuedonexerciseofoptionsinshares": 3103622,
    "sharesissuedonexerciseofoptions": 1665905,
    "sharesissuedtorelatedparty": 2000000,
    "shareissuedtorelatedparty": 920000,
    "sharebasedpayments": 1172812,
    "reserveofsharebasedpayments": 1050237,
    "sharesissuecapitalraising": 16100000,
    "shareissueconversionconvertiblenoteinshares": 3010410,
    "shareissueconversionconvertiblenote": 3125964,
    "lessshareissuecost": -2856327,
    "totalshares": 166749382,
    "totalamount": 61822859,
    "profitlossattributabletoordinaryequityholdersofparententity": 9338100,
    "othercashandcashequivalents": 6011368,
    "fairvaluevestingexpenseofoptionsandperformancerightsinshares": 6532583,
    "fairvalueofoptionsperformancerightsexercisedduringtheyear": -2487502,
    "numberofshareoptionsvestedinsharebasedpaymentarrangement": 2408333,
    "exercisepriceindollarspershare": 1.5,
    "numberofvesteddateinsharebasedpaymentarrangement": "7 Feb 2022",
    "numberofexpirydatesharebasedpaymentarrangement": "7 Feb 2025",
    "sharesreservedforissueunderoptionsandcontractsforsaleofshares": 3240000,
    "outstandingbalances": 1.131,
    "grantedduringstheyear": 840000,
    "grantedduringtheyear": 1.433,
    "exercisedduringstheyear": -2408333,
    "exercisedduringtheyears": 0.316,
    "forfeitedcancelledduringtheyears": -65000,
    "forfeitedcancelledduringtheyearindollars": 0.6,
    "exercisables": 3240000,
    "exercisable": 1.131,
    "dategranted": "7 Feb 2022",
    "numberofoptionsgranted": 140000,
    "exerciseprice": 1.1,
    "expirydate": "18 Jan 2025",
    "riskfreeinterestrateused": 0.0139,
    "volatilityapplied": 0.958,
    "valueperoption": 0.184,
    "noofrights": 2000000,
    "expirysdate": "16 Dec 2025",
    "fairvalueperrightatgrantdate": 0.93,
    "vestingsone": "Vested, not exercised",
    "numberofoutstandingshareoptions": 3000000,
    "disposaldate1": "3 Sep 2021",
    "parvaluepershare": 0.185,
    "vesting": "Vested and exercised",
    "sharesissuedforservicesrenderedinrelationtothenasdaqlisting": 979638,
    "sharesissuedtodirectorsasremunerationin": 920000,
    "employeesremuneration": 6394571,
    "directorsremunerationexpense": 112188,
    "advisersremuneration": 25824,
    "expensesarisingfromreinsuranceheld": 8432221,
    "weightedaverageinterestrate": 0.1,
    "carryingamount": 1662153,
    "contractualcashflows": 1662153,
    "notlaterthansixmonths": 1662153,
    "financialassets": 803072,
    "financialliabilities": 1161384,
    "otherfinancialassets": 6011368,
    "profitorlossincrease": 60114,
    "profitorlossdecrease": 60114,
    "equityincrease": 60114,
    "equity1decrease": 60114,
    "tradeandotherreceivables": 51176,
    "tradeandotherpayablesrecognisedasofacquisitiondate": 500769,
    "interestexpenseonborrowings": 1110171,
    "grossleaseliabilities": 51213,
    "profitlossattributabletononcontrollinginterests": 4400391,
    "keymanagementpersonnelcompensationshorttermemployeebenefits": 695325,
    "keymanagementpersonnelcompensationsharebasedpayment": 7309715,
    "keymanagementpersonnelcompensationpostemploymentbenefits": 48350,
    "keymanagementpersonnelcompensation": 8053390,
    "otherscurrentassets": 1803,
    "investmentbroughttoaccountatcost": 680,
    "shareofprofitlossofassociatesandjointventuresaccountedforusingequitymethod": -680,
    "interestandothercosts": 16771,
    "foreignexchangemovement": -20903,
    "provisionforimpairment": -696779,
    "auditorsremunerationforauditservices": 159900,
    "auditorsremunerationforpkfbrisbaneauditservices": 95000,
    "auditorsremunerationfortaxservices": 13300,
    "auditorsremunerationforotherservices": 3500,
    "auditorsremuneration": 271700,
    "otherreserves": 9338100,
    "liabilitiesandstockholdersequity": 8669512,
    "unlistedshares": 2565082,
    "cancellationoftreasuryshares": 2565082,
    "triageinvestment": 2565082,
    "additionsotherthanthroughbusinesscombinationspropertyplantandequipment": 3116171,
    "financeincomeexpensesfromreinsurancecontractsheldrecognisedinprofitorloss": -551089,
    "provisionforimpairment1": 2565082,
    "increasedecreaseofrestrictedinvestments": 2565082,
    "impairmentloss": 2565082,
    "othergainslosses": 2565082,
    "increasedecreaseinnetassetsavailableforbenefits": 2565082,
    "operatingloss": 20076843,
    "sharebasedpayment": 9956973,
    "operatinginsuranceandclaimscostsproduction": 2927030,
    "otheradjustmentsfornoncashitems": 7192840,
    "cashflowsfromusedinoperation": 9858799,
    "capitalcommitments": 16100000.000000002,
    "adjustmentsfordepreciationandamortisationexpenseandimpairmentlossreversalofimpairmentlossrecognisedinprofitorloss": 2565082,
    "securitydeposit": 37500,
    "taxprepaymentloanreceived": 700000,
    "borrowingsinterestrate": 0.05,
    "leaseagreement": 3,
    "undiscountedfinanceleasepaymentstobereceived": 299129,
    "incrementalborrowingpercentage": 0.1,
    "interestexpenseonleaseliabilities": 211191,
    "descriptionoflineitemsinstatementoffinancialpositionwhichincludeleaseliabilities": "During the financial year, A$23,589 (2021: A$38,108) interest on thelease was expensed as financing costs.",
    "numberofshareoptionforfeitedinsharebasedpaymentarrangement": 787999,
    "commonstocksharesissued": 9090,
    "numberofoptionsoutstandingoverunissuedordinaryshares": 3240000,
    "exercisepriceofoutstandingshareoptions2019": 1.5,
    "weightedaverageremainingcontractuallifeofoutstandingshareoptions2019": 14.6,
    "optionsoutstandinginsharebasedpaymentarrangement": 138012,
    "impairmentlossonfinancialassets": 1524752,
    "cashbondatlandlord": 37500,
    "cash": 3000000,
    "agreementinvestprice": 3000000,
    "benefitspaidorpayable": 150000,
    "commitedremainingbalance": 50000,
    "bankoverdrafts": 600000,
    "amountpaid": 600000,
    "investmentfundsamountcontributedtofairvalueofplanassets": 80000,
    "commitmentamount": 60000,
    "revenuefromrenderingofservicesrelatedpartytransactions": 189765,
    "loansandreceivables": 45592,
    "receivables": 171500,
    "unsecuredearninterest": 0.025,
    "convertedtermyear": 2,
    "fullydilutedbasispercentage": 0.54,
    "proportionofownershipinterestinjointventure": 0.5,
    "issueofconvertibleinstrument": 670333,
    "totalequitystake": 6000000,
    "ordinarysharesvalue": 3000000,
    "paymentstoacquirebusinessesnetofcashacquired": 3000000,
    "businesscombinationstepacquisitionequityinterestinacquireepercentage": 0.1519,
    "convertiblenotefundraising": 670833,
    "percentageofconvertiblenotes": 0.54,
    "percentageofearninterest": 0.085,
    "loansassumed1": 803072,
    "depositliabilitiesaccruedinterest": 55354,
    "longtermdebtpercentagebearingfixedinterestrate": 0.2851,
    "entityregistrantname": "ADVANCED HEALTH INTELLIGENCELTD",
    "tradingsymbol": "AHI",
    "documenttype": "20-F",
    "currentfiscalyearenddate": "June 30",
    "entitycommonstocksharesoutstanding": 166749382,
    "amendmentflag": "false",
    "entitycentralindexkey": 1815436,
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entitywellknownseasonedissuer": "No",
    "documentperiodenddate": "June 30, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "entityemerginggrowthcompany": "true",
    "entityshellcompany": "true",
    "entityextransitionperiod": "false",
    "icfrauditorattestationflag": "false",
    "documentregistrationstatement": "false",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "documentshellcompanyreport": "false",
    "entityfilenumber": "000-49843",
    "entityincorporationstatecountrycode": "Australia",
    "entityaddressaddressline1": "71-73 South Perth Esplanade",
    "entityaddressaddressline2": "Unit 5",
    "entityaddresscityortown": "South Perth",
    "entityaddresspostalzipcode": "WA 6151",
    "entityaddresscountry": "Australia",
    "contactpersonnelname": "Mr Nicholas Prosser",
    "cityareacode": 61,
    "localphonenumber": "8 9316 9100",
    "security12btitle": "American Depositary Shares, each representing seven Ordinary Shares",
    "securityexchangename": "NASDAQ",
    "entityinteractivedatacurrent": "Yes",
    "documentaccountingstandard": "International Financial Reporting Standards",
    "auditorname": "PKF BRISBANE AUDIT",
    "auditorfirmid": 6622,
    "auditorlocation": "Brisbane, Australia"
  }
]